You have access
CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma
YOHEI SEKINO, KENSHIRO TAKEMOTO, DAIKI MURATA, TAKASHI BABASAKI, KOHEI KOBATAKE, HIROYUKI KITANO, KENICHIRO IKEDA, KEISUKE GOTO, SHOGO INOUE, TETSUTARO HAYASHI, DAIKI TANIYAMA, MASANOBU SHIGETA, KAZUYA KURAOKA, KOJI MITA, MAYUMI KANEKO, KAZUHIRO SENTANI, NAOHIDE OUE and JUN TEISHIMA
Anticancer Research October 2021, 41 (10) 4875-4883; DOI: https://doi.org/10.21873/anticanres.15301